Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
Yahoo Finance Live anchors discuss reports that Apple has ditched plans to increase iPhone 14 production.
Dividends can offer fat full-time income. But the math needs to work.
Yahoo Finance Live anchors discuss Biogen stock performance on promising Alzheimer’s drug trial data.
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
General Motors CEO Mary Barra yesterday apologized to salaried workers for the timing of a memo sent late Friday afternoon outlining a new back-to-office policy and delayed the implementation of the plan. The email said that GM employees who had been working remotely during the pandemic would be required later this year to return to the office at least three days a week, the Detroit Free Press reported. The email triggered employee pushback about both the updated policy and the timing of the announcement, leading Barra to partially walk back the decision, announcing Tuesday that the automaker will not implement the requirement this year but that “a more regular, in-person presence” will still be the plan for the future.
Yahoo Finance's Allie Garfinkle discusses news that Apple has asked suppliers to pull back production by up to 6 million units and what it signals about consumer demand ahead of the holiday season.
Shares of beaten-down big tech stocks Nvidia (NASDAQ: NVDA), Meta Platforms (NASDAQ: META), and Palantir Technologies (NYSE: PLTR) bounced back today, rising 2%, 3.4%, and 2.8%, respectively, as of 11:34 a.m. ET. There wasn't much company specific news from these three today, but their shares being down so much on the year already, combined with some marginally favorable news this morning on interest rates and geopolitics, was enough to get their stocks moving higher. Equity investors may not have noticed, but Treasury Bond yields may be determining your stock portfolio performance this year more than you think -- especially when it comes to technology growth stocks.
Marijuana stocks continued to rebound from last week's sell-off on Wednesday, with shares of Canopy Growth (NASDAQ: CGC) gaining 4.2%, Tilray Brands (NASDAQ: TLRY) up 4.8%, and Aurora Cannabis (NASDAQ: ACB) leading the whole pack higher with a 5.4% gain as of 1:40 p.m. ET. The Nasdaq -- to which index all three of these cannabis stocks belong -- is up 1.5% in midafternoon trading. This morning, Canopy announced that in an effort to progress from losses toward profitability, it will divest its Canadian Tweed and Tokyo Smoke retail operations and focus in the future on producing "premium" branded cannabis as a consumer packaged goods company.
Ocugen Inc. (NASDAQ: OCGN) of Malvern entered into an exclusive license agreement Wednesday with Washington University in St. Louis for the rights to develop, manufacture and commercialize its proprietary, intranasally delivered Covid-19 vaccine in the United States, Europe, and Japan. It becomes the second Covid vaccine licensed by Ocugen, which continues to seek Food and Drug Administration approval for use of the other product, Covaxin, in the U.S. market. Under the financial terms of the deal, disclosed in documents filed with the Securities and Exchange commission, Ocugen will pay Washington University an initial license issuance fee of $1 million.
In this article, we will discuss the 10 dividend paying stocks you should avoid according to Morgan Stanley’s quant screen. If you want to read about similar stocks, you can also take a look at 5 Dividend Paying Stocks You Should Avoid According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Sherry Paul: “It’s a Buying […]
In this article, we will be taking a look at the 10 companies that are buying back their stock in 2022. To skip our detailed analysis of these companies, you can go directly to see the 5 Companies that are Buying Back Their Stock in 2022. So far in 2022, we have seen a number of […]
The Dow Jones Industrial Average rose Wednesday, ahead of Fed chief Powell's speech, struggling to avoid a seventh straight decline.
Yahoo Finance Live checks out Netflix's shares after Atlantic Equities upgrades the company's stock to "Neutral" and the streaming platform announces plans to limit password sharing.
Invesco Chief Global Market Strategist Kristina Hooper joins Yahoo Finance Live to discuss central bank policy, bond yields, and the Bank of England's recent course of action.
Creating reliable streams of retirement income is one of the most important elements of a person's financial plan. A retirement industry giant says it now has a new way for retirees to meet this vital challenge. Fidelity Investments plans to … Continue reading → The post There's a New Way to Convert Your 401(k) into a Pension-like Stream of Income appeared first on SmartAsset Blog.
In this article, we discuss 12 best Asian stocks to buy today. If you want to read about some more Asian stocks, go directly to 5 Best Asian Stocks To Buy Today. Higher energy and food prices are impacting the economies of developing Asian countries more than the rest of the world. According to a […]
In this article, we discuss 10 most shorted stocks in the world. If you want to see more stocks on this list, click 5 Most Shorted Stocks in the World. Short squeezes have rapidly gained popularity in the last two years, when retail investors on Reddit gathered to initiate bullish positions in stocks that were […]
The benchmark S&P 500, which is typically viewed as the best barometer of stock market health, produced its worst first-half return in 52 years. As for the growth-driven Nasdaq Composite, an index largely responsible for pushing the stock market to new highs, it's lost about a third of its value. This puts both the S&P 500 and Nasdaq firmly in a bear market.
My children have inherited $5 million of stock from their father (whose estate has not yet been dispersed after 11 months) leaving them with a 30% or so loss of value over which they have had no control. Is there … Continue reading → The post Ask an Advisor: My Kids Inherited $5 Million. How Should They Handle It? appeared first on SmartAsset Blog.